Search results
AARP Medicare Advantage 2024 Review - NerdWallet
Nerdwallet· 6 days agoBacked by big hitter UnitedHealthcare, AARP Medicare Advantage plans have low-cost options and just-above-average star ratings.
Man vs. Machine: Federal Employees - Medicare and FEHB
TheStreet.com· 2 days agoMan vs. Machine: ChatGPT tackles FEHB plans & Medicare. Expert critique inside!
TONI SAYS: Please simplify Medicare’s enrollment process
Odessa American· 1 day agoMy friends are advising me if I do not sign up for Medicare when I turn 65, I will be making a major Medicare mistake. Can you please simplify the
Aetna vs. Anthem: Medicare Advantage Comparison - NerdWallet
Nerdwallet· 2 days agoAetna offers Medicare Advantage plans in more states and covers nearly twice as many members as...
Medicare could save $500 million with coverage change
Newsweek· 1 day agoAnti-obesity medications are a hot topic in the medical world, and many Americans remain conflicted...
Angst over looming Chevron decision on health care
Politico· 6 hours agoWuXi AppTec flew executives, including Richard Connell, the company’s U.S. and EU president, to Washington as part of the push. Elizabeth Steele, one of ...
What Medicare beneficiaries need to know about generic medications
Fortune· 2 days agoJust ask Susan Jaquith, a retired teacher in Wilson, N.C., who’d been paying about $2,000 a year for a brand-name blood pressure medication and ...
Bipartisan bill to modernize radiation oncology re | Newswise
Newswise· 2 days agoThe Radiation Oncology Case...Act of 2024, sponsored by Sen. Thom Tillis (R-N.C.) (S. 4330) and by Reps. Brian Fitzpatrick (R-Pa.), Jimmy Panetta (
Medicaid “unwinding” decried as biased against disabled people in Colorado, elsewhere
Denver Post· 6 hours agoA home health aide showed up April 12. Saa said she’s thankful but feels anxious about the future....
Summary and Key Considerations of Recent HHS-OIG Advisory Opinion on Pharmaceutical Patient...
JD Supra· 4 days ago...unprecedent move, OIG set a time limit for the advisory opinion, terminating it two years after the full implementation of the Medicare Part D benefit redesign established through the Inflation Reduction Act of 2022 (IRA). ...factors in the arrangement, including: the rare disease patient...